Is Target a Dividend King?
Popular retail giant Target Corporation (NYSE:TGT) has been in a…
Sell
18
VNDA Quote, Financials, Valuation and Earnings
Last price:
$4.39
Seasonality move
:
-4.37%
Day range:
$4.43 - $4.60
52-week range:
$3.46 - $6.75
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.38x
P/B ratio:
0.49x
Volume:
614.7K
Avg. volume:
630.2K
1-year change:
17.66%
Market cap:
$264.1M
Revenue:
$192.6M
EPS (TTM):
-$0.28
Vanda Pharmaceuticals SEC Filings
| Company | Filed | Form Type | Description | |
|---|---|---|---|---|
|
VNDA
Vanda Pharmaceuticals
|
05/09/2024 | 10-Q | 10-Q filing on 05/09/2024 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
11/09/2023 | 10-Q | 10-Q filing on 11/09/2023 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
07/28/2023 | 10-Q | 10-Q filing on 07/28/2023 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
05/03/2023 | 10-Q | 10-Q filing on 05/03/2023 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
11/03/2022 | 10-Q | 10-Q filing on 11/03/2022 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
08/04/2022 | 10-Q | 10-Q filing on 08/04/2022 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
05/06/2022 | 10-Q | 10-Q filing on 05/06/2022 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
11/04/2021 | 10-Q | 10-Q filing on 11/04/2021 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
07/29/2021 | 10-Q | 10-Q filing on 07/29/2021 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
05/06/2021 | 10-Q | 10-Q filing on 05/06/2021 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
10/29/2020 | 10-Q | 10-Q filing on 10/29/2020 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
08/06/2020 | 10-Q | 10-Q filing on 08/06/2020 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
05/07/2020 | 10-Q | 10-Q filing on 05/07/2020 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
02/26/2020 | 10-K | 10-K filing on 02/26/2020 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
11/07/2019 | 10-Q | 10-Q filing on 11/07/2019 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
08/01/2019 | 10-Q | 10-Q filing on 08/01/2019 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
05/03/2019 | 10-Q | 10-Q filing on 05/03/2019 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
02/19/2019 | 10-K | 10-K filing on 02/19/2019 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
11/07/2018 | 10-Q | 10-Q filing on 11/07/2018 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
08/02/2018 | 10-Q | 10-Q filing on 08/02/2018 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
05/02/2018 | 10-Q | 10-Q filing on 05/02/2018 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
02/15/2018 | 10-K | 10-K filing on 02/15/2018 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
11/08/2017 | 10-Q | 10-Q filing on 11/08/2017 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
08/03/2017 | 10-Q | 10-Q filing on 08/03/2017 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
05/03/2017 | 10-Q | 10-Q filing on 05/03/2017 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
02/17/2017 | 10-K | 10-K filing on 02/17/2017 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
11/03/2016 | 10-Q | 10-Q filing on 11/03/2016 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
07/28/2016 | 10-Q | 10-Q filing on 07/28/2016 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
05/05/2016 | 10-Q | 10-Q filing on 05/05/2016 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
02/12/2016 | 10-K | 10-K filing on 02/12/2016 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
11/04/2015 | 10-Q | 10-Q filing on 11/04/2015 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
07/31/2015 | 10-Q | 10-Q filing on 07/31/2015 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
06/10/2015 | 10-K | 10-K filing on 06/10/2015 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
05/07/2015 | 10-Q | 10-Q filing on 05/07/2015 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
03/13/2015 | 10-K | 10-K filing on 03/13/2015 | View Form |
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is COWZ ETF a Good Investment?
There’s a reason even Warren Buffett advocates his heirs to…
3 Stocks Buffett Is Betting On
Warren Buffett appeared to take a hard look at the…
Stock Ideas
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 39x
Sell
46
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 112x
Sell
40
Is MSFT Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
61
ITCI alert for Jan 14
Intra-Cellular Therapies [ITCI] is down 0.26% over the past day.
Sell
30
ESTA alert for Jan 14
Establishment Labs Holdings [ESTA] is down 1.51% over the past day.
Buy
72
DJT alert for Jan 14
Trump Media & Technology Group [DJT] is down 8.25% over the past day.
